This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Waterstone Pharmaceuticals (Wuhan) Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Jian Cui: Inventor in Hyperuricemia Treatment
Introduction
Jian Cui is an inventor based in Wuhan, China. His work includes a patent disclosure concerning polymers and compositions designed to bind uric acid or its precursors and potentially support treatment for hyperuricemia, gout, and related diseases.
Latest Patents
Cui is associated with 1 patent: “Polymers, Compositions and Methods for Treating Hyperuricemia.” The disclosure describes small-molecule compounds, polymers, and compositions, along with methods for preparing them. It also describes using these materials to bind uric acid or its precursors and to address hyperuricemia, gout, and diseases caused by hyperuricemia.
Career Highlights
Cui is associated with Waterstone Pharmaceuticals (Wuhan) Co., Ltd. and Waterstone Pharmaceuticals. The available information identifies his work in pharmaceutical research related to approaches for managing uric acid and hyperuricemia.
Collaborations
Cui’s listed coworkers include Youcheng Zhou and Tongtong Li. Their names are associated with his professional and patent-related work.
Conclusion
Jian Cui’s patent work focuses on polymer-based compositions and methods with potential applications in binding uric acid and treating hyperuricemia and related conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile